Jefferies Group’s Charles River Laboratories CRL Stock Holding History

Jefferies Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-17,800	Closed	-$1.25M	–	2393
2015 Q2	$1.25M	Buy	+17,800	New	+$1.32M	0.01%	1144
2014 Q4	–	Sell	-93,600	Closed	-$5.59M	–	1999
2014 Q3	$5.59M	Buy	93,600 +72,900	+352%	+$4.17M	0.04%	389
2014 Q2	$1.11M	Buy	+20,700	New	+$1.14M	0.01%	870

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jefferies Group's CRL Position: Q3 2022 in Review

Jefferies Group opened a new position in Charles River Laboratories (CRL) in Q3 2022: 3,122 shares worth $614K. The stake represents 0.01% of the portfolio and ranks #968 among its holdings. This is a return to the name: Jefferies Group previously reported a position in CRL as recently as Q2 2021.

Jefferies Group first reported a position in CRL in Q3 2013 and has held it in 27 quarters since. The position peaked at $11.1M in Q1 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

Jefferies Group held 3,122 shares of Charles River Laboratories worth $614K as of Q3 2022.
Charles River Laboratories was a new Jefferies Group position in Q3 2022.
Charles River Laboratories made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #968 holding.
Jefferies Group first reported a position in Charles River Laboratories in Q3 2013 and has held it in 27 quarters since.
Jefferies Group's Charles River Laboratories position peaked at $11.1M in Q1 2021.
583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.